CASP, the protein structure prediction contest that launched DeepMind’s Alphafold to international fame and a Nobel Prize, ...

In contrast to AI-driven drug discovery companies like Xaira, Recursion, or DeepMind spinout Isomorphic Labs, which focus on ...

X, an internet-based generative AI tool that enables scientists to design protein binders with no coding required. The ...

Google’s GNoME AI might be the most important scientific discovery tool since AlphaFold. By identifying novel, stable ...

A three-decade-old competition that has spawned three Nobel laureates is becoming victim to the chaos at the National Institutes of Health.

BioEmu, a new deep learning system, predicts protein shapes quickly and accurately, complementing traditional molecular ...

Google’s longtime AI guru has quietly backed more than 30 startups in the past two years—offering founders early credibility ...

Quantum computing could revolutionise protein modelling by enabling simulations of molecular behaviour at atomic resolution.

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...